Oman Blood Glucose Monitoring Market Size & Share Analysis - Growth Trends and Forecast (2027 - 2032)

Oman Blood Glucose Monitoring Market Trends and Insights

Rising diabetes prevalence

In Oman, Diabetes Population is expected to increase with a CAGR greater than 10.4% over the forecast period.

According to Mordor Intelligence, the type-2 diabetic population in Oman increased to 0.57 million in the current year and it is expected to reach 0.84 million during the forecast period. Although the current numbers show that the existence of diabetes is comparatively lesser in Oman, the growth rate of the diabetic population is projected to be higher in the country. Moreover, the number of new cases among children is about 60 cases annually. According to local studies and reports on good diabetes control, the rate in adult patients ranges from 32-35%, whereas reaches 10-12% among children and adolescents. The Government is working on increasing awareness of diabetes, in addition, to access to sugar monitors to improve good diabetes control for children.

Various local studies suggest that the changing lifestyle of the Omani population has led to increased obesity which contributes to the rising cases of diabetes. Omanis are less engaged in physical activity and consume more sugar and saturated fats. Traditionally, Omani people consume unhealthy foods, sweets, sugary beverages, and high-carbohydrate foods.

According to IDF latest annual report, 73 million adults (20-79) are living with diabetes in the IDF MENA Region. This figure is estimated to increase to 95 million by 2030. Diabetes poses an emerging healthcare burden across the country and is one of the leading causes of premature death, morbidity, and loss of economic growth. Technological development is gaining momentum in the glucose monitoring market. Over the years, several technological innovations have been developed that have led to the creation of new types of devices that are much less cumbersome and more comfortable for patients compared to traditional ones. Such advantages have helped the rise in the adoption of these products in the market.

The Continuous Glucose Monitoring Segment is Expected to Witness Highest Growth Rate Over the Forecast Period

The Continuous Glucose Monitoring Segment is expected to further increase with a CAGR of more than 10.84% during the forecast period.

A continuous Glucose Monitoring Device is a compact medical system that continuously monitors blood glucose levels in real time. A small sensor is inserted into the abdomen or arm with a cannula penetrating the top layer of skin. An adhesive patch holds the sensor in place, allowing it to take glucose readings throughout the day and night. Generally, the sensor must be replaced every 7 to 14 days. A small reusable transmitter connected to the sensor allows the system to send real-time readings wirelessly to a monitor device or a smartphone app that displays blood glucose data. These devices eliminate the need for regular fingerstick tests and serve as important outpatient blood sugar management options for reducing A1C. They help increase the user’s time-in-range (TIR), the overall percentage of time spent in a healthy glucose range, and are beneficial for active children and adults, for ensuring safety during physical activity and nighttime glucose fluctuations.

According to Oman Diabetes Association, diabetes is a costly chronic illness that needs control of blood sugar levels using medical devices. This imposes a challenge for low-income and social security patients. Thus, an initiative has been designed to reduce the burden on these targeted groups, consequently promoting sugar control. Oman under the ODA initiative is trying to aware diabetes patients about the usage of blood glucose devices. The Ministry of Health, Oman is strategically planning to contain the growing burden of diabetes and invest in all means to control it, stating “our work needs to ensure equitable and affordable access to treatment, and it is essential that we advocate for investments in diabetes education and prevention programs”.

The blood glucose monitoring market in Oman is benefiting from the gradual shift toward advanced diabetes management technologies. Healthcare providers are increasingly incorporating CGM systems and smartphone-connected glucose monitoring devices to improve patient adherence and reduce diabetes-related complications. This trend, combined with rising awareness of continuous glucose tracking among diabetes patients, is expected to drive market growth over the forecast period.